ArticleTherapeutic advances in medical oncology2026
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.
Davide Bimbatti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.